Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Shrinking Youth Group Aids Global Decline in HomicidesWhen Meds Are Free, Patients Take Them More OftenSpurred by Mass Shootings, More Americans View Mentally Ill as ViolentPacemakers, Insulin Pumps Could Be Hacking Targets: FDAAHA News: Make Neighborhoods Green for Heart Health? The Idea Is Taking RootPoll Finds Many Young Americans Think Vaping is SafeWhat Do Hospital Cyber Attackers Want to Know About You?U.S. Minorities' Recent Health Gains May Be SlowingPaid Family Leave Helps Keep Babies' Vaccines on Track: StudyDon't Let Fear of Cancer Keep You From Doctor VisitsMaker Halts Distribution of Generic Zantac Due to Possible CarcinogenCould Profit Be a Factor in Kidney Transplant Decisions?Get Up-to-the-Minute Safety Alerts Sent Straight to Your InboxPurdue Pharma to Settle Opioid Crisis Lawsuits, May Pay Up to $12 BillionWould a Health Warning on Every Cigarette Help Smokers Quit?Docs Prescribe More Opioids at Certain Time of DayFDA Warns Juul About Illegal Marketing Claims and Pitch to YouthComing Soon: A 'Pot Breathalyzer'?More CT, MRI Scans Being Used, Despite Calls to Cut BackCancer Overtakes Heart Disease as #1 Killer of Middle-Aged in Wealthy NationsOxyContin Maker Purdue Offering Up to $12 Billion to Settle Opioid ClaimsThousands of Kidneys Thrown Away by U.S. Transplant CentersJudge Orders Johnson & Johnson to Pay $572 Million Over Opioid Drug CrisisEvery Sudden Infant Death Deserves a Closer Look: ReportYour Chocolate Pot 'Edible' Could Hold a Hidden DangerCBD Is the Rage, But More Science Needed on Safety, EffectivenessMany Parents Would Switch Doctors Over Vaccination Policy, Poll FindsPot Poisonings Among Kids, Teens Double After Medical Marijuana Law PassedNearly Half of U.S. Patients Keep Vital Secrets From Their DoctorsFDA Proposes Graphic Warning Labels on CigarettesMany Doctors Refusing Care of People Prescribed OpioidsAll U.S. Adults Should Be Screened for Illicit Drug Use, National Panel UrgesAmericans' Trust in Scientists Follows a Sharp Political DivideRaising Legal Smoking Age to 21 WorksPure CBD Won't Make You Fail a Drug Test, But…Health Tip: Donate Blood SafelyRoutine Screening for Pancreatic Cancer Not Warranted, Expert Panel SaysResearchers 'Spin' Clinical Trial Findings in Top Psych Journals: StudyMore 'Buyer Beware' Warnings for Unregulated Stem Cell ClinicsSome of Most Common, Deadly Cancers Get the Least Research MoneyTraveling Abroad? Make Sure Your Measles Shot Is Up to DateHey! That's the Wrong Knee, DoctorBlood Donations Needed: Red CrossKeep Unused Meds Out of the Hands of AddictsFew U.S. Universities Are Smoke-FreeNeed Emergency Air Lift to Hospital? It Could Cost You $40,000California Took on Anti-Vaxxers, and WonAnti-Vaccine Movement a 'Man-Made' Health Crisis, Scientists WarnAHA News: Even the Threat of Homelessness May Bring Higher Stroke RiskFDA Warns Two Kratom Marketers About False Claims
Questions and AnswersVideosLinksBook Reviews
Related Topics

Health Insurance
Healthcare

Drugstores Often Don't Have Opioid Antidote in Stock, Philly Study Shows

HealthDay News
by -- Steven Reinberg
Updated: Jun 7th 2019

new article illustration

FRIDAY, June 7, 2019 (HealthDay News) -- Even though the drug naloxone can be a lifesaving antidote to an opioid overdose, researchers in Philadelphia report that only a third of drugstores in that city carried it.

What's more, although Pennsylvania's standing order law for naloxone (common brand name: Narcan) allows pharmacists to dispense the drug without a doctor's prescription, many pharmacies refused to give the nasal spray without a doctors' OK, the study authors said.

The intent of the law was to encourage pharmacists to give the drug to anyone who asked for it. The impetus for the law was to try to curb the growing number of deaths from opioid overdoses.

Not implementing these laws puts unnecessary barriers in the way of those who need this medicine most, said study co-author Dima Qato, an associate professor of pharmacy systems, outcomes and policy at the University of Illinois at Chicago College of Pharmacy.

"Efforts to strengthen the implementation of naloxone access laws, including statewide standing orders, which are considered the least restrictive, are warranted," Qato said in a university news release. "Particularly for pharmacies located in communities with the highest rates of death due to opioid overdose."

For the study, researchers surveyed Philadelphia drugstores by phone in 2017.

Of the more than 400 drugstores surveyed, only 34% had naloxone available. Chain pharmacies were more likely to stock it than independent ones.

Naloxone was also less likely to be found in minority neighborhoods than in white neighborhoods. It was also not likely to be found in areas with the highest number of drug overdose deaths, the researchers noted.

In addition, of those stores that did stock naloxone, 40% asked for a doctor's prescription and many would not give the drug to those under 18.

Laws are not enough, according to Qato. "Policies need to be enforced and pharmacies need to be aware of and held accountable for implementing them," she said.

A new law now requires pharmacies to "stock naloxone and to post a sign notifying shoppers that it is stocked," said researcher Jenny Guadamuz, also from the University of Illinois.

"Pharmacies can be fined $250 for each day they are not in compliance of the law. Now, the question is, will the city enforce the law?" Guadamuz said.

The report was published online June 7 in the journal JAMA Network Open.

More information

The U.S. National Institute on Drug Abuse has more information on naloxone.




Facebook

Amazon Smile

To quit smoking, call Connecticut QuitLine at 1-800-QUIT-NOW.

Children and Adult services are available now with no wait time.  Please contact HBH Intake Department at 860-548-0101, option 2.

 


powered by centersite dot net